NHS Clinical Commissioners (NHSCC) and NHS England have developed a proposal to improve patient care by no longer routinely prescribing 18 medicines which are either:
• Clinically ineffective; unsafe; or not cost effective; or
• Where the NHS can offer a clinically-proven alternative for patients.
In partnership NHS England and NHSCC brought together an expert clinical working group earlier this year to review the evidence, and they have developed recommendations for a public consultation.
The objective is to produce commissioning guidance to support clinical commissioning groups (CCGs) in their decision-making, to address unwarranted variation, and to provide clear national advice to make local prescribing practices more effective. Any savings from implementing the proposals will be reinvested in improving patient care.
The consultation is open from 21 July to 21 October 2017.
NHS England and NHSCC are also seeking people’s views on whether a wider list of 3,200 products that are available over-the-counter, without prescription, may be considered appropriate for future restriction. At this stage, we are seeking views generally on this area, for further work and consideration by the clinical working group.
Please respond to the consultation and share through your networks.